Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy

Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy

US Patent 10385138 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized and variant TGF-β1 specific antibodies and methods and uses thereof2025
Anti-CTLA-4 antibodies and methods of use thereof2025
Anti-CTLA-4 antibodies and methods of use thereof2025
Antibodies and methods of use thereof2024
Anti-GITR antibodies and methods of use thereof2024
Anti-CTLA-4 antibodies and methods of use thereof2023
Methods of administering anti-OX40 antibodies2022
Antibodies and methods of use thereof2022
Anti-GITR antibodies and methods of use thereof2022
Anti-OX40 antibodies and anti-GITR antibodies2022
Anti-PD-1 antibodies and methods of use thereof2022
Vectors comprising nucleic acids encoding anti-OX40 antibodies2022